Euro tumbles after unexpected resignation of new French Prime Minister
WINSFORD, UK - Advanced Medical Solutions Group plc (AIM:AMS) announced that CEO Chris Meredith transferred 50,510 ordinary shares through a sale and repurchase transaction on September 24, 2025, as part of what the company described as normalized tax planning.
According to the company statement, Meredith sold the shares, previously held in the name of Platform Securities Nominees Limited, at a price of 218.5p per share. He then repurchased the same number of shares at 218.54p per share, distributing them across Individual Savings Accounts (ISAs) and Self-Invested Personal Pensions (SIPPs) held by himself and his wife Ingrid Meredith, as well as to his adult children.
The transaction included 9,934 shares purchased into Chris Meredith’s ISAs, 9,932 shares into Ingrid Meredith’s ISAs, 2,257 shares into Chris Meredith’s SIPPs, and 1,300 shares into Ingrid Meredith’s SIPPs.
The company noted that the beneficial ownership of the shares remains unchanged following these transactions, with no change to the total number of shares held by the CEO and his family.
Advanced Medical Solutions, which describes itself as a specialist in tissue-healing technologies, made the disclosure in accordance with EU Market Abuse Regulation requirements. The transactions were conducted on the London Stock Exchange’s AIM Market.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.